Health Care Abiomed, Inc. (ABMD) Q3 2021 Earnings Call Transcript 5 years ago Abiomed, Inc. (NASDAQ: ABMD) Q3 2021 earnings call dated Jan. 28, 2021 Corporate Participants: Todd A. Trapp -- Vice President and Chief… Abbott Laboratories (ABT) Q4 2020 Earnings Call 5 years ago Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021. Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing and… Abbott Laboratories (ABT) Q4 2020 Earnings Call Transcript 5 years ago Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021. Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing… ABT Earnings: Key numbers from Abbott Laboratories Q4 financial results 5 years ago Abbott (NYSE: ABT) today announced its fourth-quarter financial results for the period ended December 31, 2020. Net earnings for the… Fate Therapeutics (FATE) looks headed for a turnaround post-COVID 5 years ago Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharma company, has been drawing the market's attention after reporting positive results from… Novartis International AG (NVS) Q4 2020 Earnings Call Transcript 5 years ago Novartis International AG (NYSE: NVS) Q4 2020 earnings call dated Jan. 26, 2021 Corporate Participants: Samir Shah -- Global Head, Investor Relations… Johnson & Johnson (JNJ): Strength in ecommerce drives growth in Consumer Health 5 years ago Shares of Johnson & Johnson (NYSE: JNJ) gained nearly 3% in morning trade on Tuesday after the company reported fourth… Johnson & Johnson (JNJ) beats market estimates in Q4 5 years ago Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2020 financial results before the regular market hours on Tuesday. The pharmaceutical giant… Merck (MRK) pulls out of the COVID-19 vaccine race; will focus on investigational therapeutic candidates 5 years ago Merck & Co. Inc. (NYSE: MRK) has decided to discontinue the development of its COVID-19 vaccine candidates after its clinical… Key highlights from Kimberly-Clark (KMB) Q4 2020 earnings results 5 years ago Kimberly-Clark Corporation (NYSE: KMB) reported fourth-quarter 2020 earnings results today. Net sales increased 6% to $4.8 billion year-over-year. Net income… Next» « Previous